GlassScriptPhysician profile
David L Ross
NPI 1912959594
$26,719.92
in general payments reported to CMS, 2019-2025
85 companies · $3,547 in 2025
The $3,547 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,170 · 2020: $3,559 · 2021: $3,903 · 2022: $4,566 · 2023: $3,479 · 2024: $4,496 · 2025: $3,547.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,343.68 |
| Education | $177.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,529.19 | 2019-2025 | Enhertu, Tagrisso, Imfinzi |
| Pfizer INC. | $2,034.89 | 2019-2025 | |
| Janssen Biotech, INC. | $1,898.69 | 2019-2025 | Tecvayli, Darzalex, Rybrevant |
| Novartis Pharmaceuticals Corporation | $1,610.21 | 2019-2025 | Kisqali, Piqray |
| E.R. Squibb & Sons, L.L.C. | $1,461.25 | 2019-2025 | Opdivo, Opdualag |
| Merck Sharp & Dohme LLC | $1,213.14 | 2019-2025 | Keytruda, Welireg, Lynparza |
| Seagen INC. | $1,118.62 | 2019-2023 | Adcetris, Padcev, Tivdak |
| Incyte Corporation | $974.28 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Amgen INC. | $870.37 | 2019-2022 | |
| Genzyme Corporation | $772.99 | 2019-2025 | |
| Genentech USA, INC. | $766.81 | 2019-2025 | Venclexta, Tecentriq, Polivy |
| Celgene Corporation | $684.68 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Abbvie INC. | $663.28 | 2019-2025 | Venclexta |
| Takeda Pharmaceuticals U.S.A., INC. | $632.06 | 2019-2025 | Fruzaqla, Alunbrig, Ninlaro |
| Daiichi Sankyo INC. | $617.44 | 2019-2025 | Enhertu, Vanflyta |
Show all 85 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $583.06 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Astellas Pharma US INC | $566.65 | 2019-2025 | Padcev, Xtandi, Veozah |
| Regeneron Healthcare Solutions, INC. | $531.86 | 2020-2025 | Libtayo |
| Glaxosmithkline, LLC. | $466.05 | 2020-2025 | Ojjaara, Zejula, Shingrix |
| Eisai INC. | $453.38 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $436.01 | 2019-2025 | |
| Pharmacyclics LLC, An Abbvie Company | $355.77 | 2019-2023 | Imbruvica |
| Jazz Pharmaceuticals INC. | $339.56 | 2020-2025 | Zepzelca |
| Gilead Sciences, INC. | $316.88 | 2019-2025 | Trodelvy |
| Ipsen Biopharmaceuticals, INC | $257.95 | 2019-2025 | Onivyde, Somatuline Depot, Tazverik |
| Karyopharm Therapeutics INC. | $243.04 | 2020-2025 | Xpovio |
| Emd Serono, INC. | $231.24 | 2020-2025 | Bavencio |
| Puma Biotechnology, INC. | $202.95 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $193.42 | 2019-2025 | |
| Servier Pharmaceuticals LLC | $191.16 | 2022-2025 | |
| Genmab U.S., INC. | $187.33 | 2024-2025 | Epkinly |
| Array Biopharma INC | $186.27 | 2020-2025 | Mektovi, Braftovi, Lorbrena |
| Kite Pharma, INC. | $185.26 | 2021-2025 | Yescarta |
| Sobi, INC | $151.55 | 2022-2025 | |
| Rigel Pharmaceuticals, INC. | $145.91 | 2019-2024 | Rezlidhia, Tavalisse |
| Pharmacosmos Therapeutics INC. | $138.03 | 2020-2025 | Monoferric, Cosela |
| Exelixis INC. | $126.54 | 2019-2025 | Cabometyx |
| Adc Therapeutics America, INC. | $124.68 | 2022-2025 | |
| Taiho Oncology, INC. | $123.32 | 2019-2024 | |
| Celltrion USA INC. | $118.61 | 2023 | Vegzelma |
| Immunomedics, INC. | $114.47 | 2020 | |
| Deciphera Pharmaceuticals INC. | $112.48 | 2021-2025 | Qinlock, Romvimza, Tgct |
| Alexion Pharmaceuticals, INC. | $111.99 | 2019-2024 | Ultomiris |
| Beigene USA, INC. | $108.97 | 2020-2024 | Brukinsa |
| Mirati Therapeutics, INC. | $98.41 | 2023 | Krazati |
| Agios Pharmaceuticals, INC. | $91.23 | 2020-2025 | Pyrukynd |
| Coherus Oncology, INC. | $90.93 | 2024-2025 | Loqtorzi |
| Pharmaessentia USA Corporation | $76.88 | 2024-2025 | Besremi |
| Myovant Sciences INC. | $70.60 | 2021-2022 | |
| Tersera Therapeutics LLC | $68.78 | 2023-2025 | Zoladex |
| Clovis Oncology, INC. | $67.04 | 2019-2022 | |
| Epizyme, INC. | $66.83 | 2020-2022 | |
| G1 Therapeutics, INC. | $65.95 | 2022-2023 | Cosela |
| Sumitomo Pharma America, INC. | $49.28 | 2023-2025 | Orgovyx |
| Tg Therapeutics, INC. | $46.80 | 2021 | |
| Dendreon Pharmaceuticals LLC | $46.65 | 2025 | Provenge |
| Beone Medicines USA, INC. | $46.22 | 2025 | Brukinsa |
| Geron Corporation | $45.25 | 2025 | Rytelo |
| Iovance Biotherapeutics, INC. | $44.19 | 2024-2025 | Amtagvi |
| Tolmar Pharmaceuticals, INC. | $38.82 | 2019 | |
| Acceleron Pharma, INC. | $36.47 | 2020-2021 | |
| Springworks Therapeutics, INC. | $35.92 | 2025 | Gomekli, Ogsiveo |
| Dova Pharmaceuticals | $35.24 | 2020-2021 | |
| Stemline Therapeutics INC. | $34.05 | 2023-2025 | Orserdu |
| Global Blood Therapeutics, INC. | $29.39 | 2020-2022 | |
| Immunocore Limited | $27.67 | 2025 | Kimmtrak |
| Biocon Biologics INC | $24.63 | 2024 | Fulphila |
| Cti Biopharma Corp. | $23.59 | 2023 | Vonjo |
| Sun Pharmaceutical Industries INC. | $22.32 | 2022 | |
| Menarini Silicon Biosystems, INC. | $21.86 | 2024 | |
| Fennec Pharmaceuticals, INC. | $21.17 | 2024 | Pedmark |
| Blueprint Medicines Corporation | $21.01 | 2023 | Ayvakit |
| Recordati_rare_diseases_inc. | $20.69 | 2025 | Enjaymo |
| Foundation Medicine, INC. | $19.92 | 2023 | |
| Advanced Accelerator Applications | $19.59 | 2019 | |
| Morphosys, US INC. | $19.40 | 2021 | |
| Legend Biotech USA INC. | $17.87 | 2025 | Carvykti |
| Tesaro, INC. | $17.17 | 2019 | |
| Amag Pharmaceuticals, INC. | $16.97 | 2022 | |
| Aveo Pharmaceuticals, INC. | $16.05 | 2025 | |
| Amneal Pharmaceuticals LLC | $16.04 | 2025 | Alymsys |
| Novocure INC. | $15.54 | 2025 | Optune Lua (Novottf-200t) |
| Macrogenics, INC. | $14.31 | 2023 | |
| Azurity Pharmaceuticals, INC. | $13.90 | 2024 | Vivimusta |
| Verity Pharmaceuticals INC. | $13.00 | 2023 | Trelstar |
Drugs and devices associated with these payments
Enhertu $755Keytruda $551Adcetris $460Xtandi $438Tecvayli $389Orgovyx $344Imbruvica $325Epkinly $324Jaypirca $296Kisqali $291Talzenna $287Elrexfio $283Padcev $263Jakafi $255Verzenio $252Darzalex $236Venclexta $208Opdivo $205Lenvima $203Lynparza $197Libtayo $195Retevmo $189Rybrevant $183Xpovio $172Ibrance $165Talvey $157Tivdak $148Reblozyl $145Sarclisa $144Carvykti $142Ojjaara $138Tukysa $138Welireg $136Brukinsa $128Fabhalta $126Bosulif $123Comirnaty $122Tagrisso $122Braftovi $119Mektovi $119Vegzelma $119Vonjo $117Erleada $113Akeega $113Balversa $113Imfinzi $105Zepzelca $105Fruzaqla $105Paxlovid $102Krazati $98.41Trodelvy $96.18Pluvicto $92.86Inlyta $88.88Piqray $87.02Alunbrig $86.79Pomalyst $85.57Vitrakvi $85.05Stivarga $85.05Qinlock $81.66Monjuvi $79.03Monoferric $78.59Lorbrena $77.02Besremi $76.88Udenyca $76.85Scemblix $75.66Onivyde $70.87Zoladex $68.78Bavencio $68.05Cabometyx $65.78Ultomiris $64.37Enjaymo $63.34Tavalisse $62.10Rezlidhia $62.10Promacta $59.66Elahere $58.93Tibsovo $56.13Veozah $54.14Pemazyre $52.36Idhifa $49.90Elitek $49.70Zynlonta $49.25Tecentriq $49.03Somatuline Depot $47.19Provenge $46.65Vyloy $46.54Tazverik $46.28Zynyz $46.09Rytelo $45.25Polivy $44.41Doptelet $44.20Amtagvi $44.19Ninlaro $41.83Cosela $41.49Voranigo $40.89Jevtana $39.59Nerlynx $39.33Iclusig $38.32Vanflyta $37.56Orserdu $34.05Zejula $33.99
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Ross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.